Abstract
At the crossroad between innate and adaptive immunity are the dendritic Cells (DCs), a “novel cell type.” discovered in 1973 by Ralph Steinman. Although not entirely appreciated at first, it is clear that they play a critical role as specialized antigen-presenting cells and essential mediators in shaping immune reactivity and tolerance. Dendritic cells are now recognized as a heterogeneous group of cells in terms of cell-surface markers, anatomic location, and function adapted to protect against an array of pathogens and conditions. Importantly, these subsets are also unique to each species. While significant progress has been made on the identification and function of mouse DC subsets, much less is known about human cells. Here we review the fascinating biology of human skin DCs and describe tolerogenic principles that are critical in maintaining immune homeostasis and for controlling inflammation, as well as mechanisms that are fundamental to confer immunity. We surmise that these principles could be applied to DCs across organs, and could be harnessed for the treatment of various human autoimmune, inflammatory diseases, as well as cancer. Importantly, to leverage the relevance of basic research to the clinical setting, it is first necessary to determine the functional homology between mouse and human DCs. We discuss practical steps towards this aim.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Artyomov, M. N., et al. (2015). Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells. The Journal of Experimental Medicine, 212(5), 743–757.
Babbitt, B. P., Allen, P. M., Matsueda, G., Haber, E., & Unanue, E. R. (1985). Binding of immunogenic peptides to Ia histocompatibility molecules. Nature, 317, 359–361.
Bachem, A., Guttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A., Salama, A., Movassaghi, K., Opitz, C., Mages, H. W., Henn, V., Kloetzel, P. M., Gurka, S., & Kroczek, R. A. (2010). Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. The Journal of Experimental Medicine, 207, 1273–1281.
Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392, 245–252.
Banchereau, J., Klechevsky, E., Schmitt, N., Morita, R., Palucka, K., & Ueno, H. (2009). Harnessing human dendritic cell subsets to design novel vaccines. Annals of the New York Academy of Sciences, 1174, 24–32.
Banchereau, J., Thompson-Snipes, L., Zurawski, S., Blanck, J. P., Cao, Y., Clayton, S., Gorvel, J. P., Zurawski, G., & Klechevsky, E. (2012a). The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood, 119, 5742–5749.
Banchereau, J., Zurawski, S., Thompson-Snipes, L., Blanck, J. P., Clayton, S., Munk, A., Cao, Y., Wang, Z., Khandelwal, S., Hu, J., McCoy, W. H. t., Palucka, K. A., Reiter, Y., Fremont, D. H., Zurawski, G., Colonna, M., Shaw, A. S., & Klechevsky, E. (2012b). Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proceedings of the National Academy of Sciences of the United States of America, 109, 18885–18890.
Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996). CD34 + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. The Journal of Experimental Medicine, 184, 695–706.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., Lanzavecchia, A., & Banchereau, J. (1997). CD34 + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood, 90, 1458–1470.
Chu, C. C., Ali, N., Karagiannis, P., Di Meglio, P., Skowera, A., Napolitano, L., Barinaga, G., Grys, K., Sharif-Paghaleh, E., Karagiannis, S. N., Peakman, M., Lombardi, G., & Nestle, F. O. (2012). Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. The Journal of Experimental Medicine, 209, 935–945.
Cohn, L., Chatterjee, B., Esselborn, F., Smed-Sorensen, A., Nakamura, N., Chalouni, C., Lee, B. C., Vandlen, R., Keler, T., Lauer, P., Brockstedt, D., Mellman, I., & Delamarre, L. (2013). Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. The Journal of Experimental Medicine, 210, 1049–1063.
Crozat, K., Guiton, R., Guilliams, M., Henri, S., Baranek, T., Schwartz-Cornil, I., Malissen, B., & Dalod, M. (2010). Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunological Reviews, 234, 177–198.
de Jong, A., Pena-Cruz, V., Cheng, T. Y., Clark, R. A., Van Rhijn, I., & Moody, D. B. (2010). CD1a-autoreactive T cells are a normal component of the human alphabeta T cell repertoire. Nature Immunology, 11, 1102–1109.
del Rio, M. L., Bernhardt, G., Rodriguez-Barbosa, J. I., & Forster, R. (2010). Development and functional specialization of CD103+ dendritic cells. Immunological Reviews, 234, 268–281.
Dresch, C., Ackermann, M., Vogt, B., de Andrade Pereira, B., Shortman, K., & Fraefel, C. (2011). Thymic but not splenic CD8(+) DCs can efficiently cross-prime T cells in the absence of licensing factors. European Journal of Immunology, 41, 2544–2555.
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H. W., Park, C. G., Steinman, R. M., & Nussenzweig, M. C. (2007). Differential antigen processing by dendritic cell subsets in vivo. Science, 315, 107–111.
Dullaers, M., Li, D., Xue, Y., Ni, L., Gayet, I., Morita, R., Ueno, H., Palucka, K. A., Banchereau, J., & Oh, S. (2009). A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity, 30, 120–129.
Flacher, V., Bouschbacher, M., Verronese, E., Massacrier, C., Sisirak, V., Berthier-Vergnes, O., de Saint-Vis, B., Caux, C., Dezutter-Dambuyant, C., Lebecque, S., & Valladeau, J. (2006). Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. The Journal of Immunology, 177, 7959–7967.
Fujita, H., Nograles, K. E., Kikuchi, T., Gonzalez, J., Carucci, J. A., & Krueger, J. G. (2009). Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proceedings of the National Academy of Sciences of the United States of America, 106, 21795–21800.
Gao, Y., Nish, S. A., Jiang, R., Hou, L., Licona-Limon, P., Weinstein, J. S., Zhao, H., & Medzhitov, R. (2013). Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity, 39, 722–732.
Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M., Dai, X. M., Stanley, E. R., Randolph, G. J., & Merad, M. (2006). Langerhans cells arise from monocytes in vivo. Nature Immunology, 7, 265–273.
Ginhoux, F., Collin, M. P., Bogunovic, M., Abel, M., Leboeuf, M., Helft, J., Ochando, J., Kissenpfennig, A., Malissen, B., Grisotto, M., Snoeck, H., Randolph, G., & Merad, M. (2007). Blood-derived dermal langerin + dendritic cells survey the skin in the steady state. The Journal of Experimental Medicine, 204, 3133–3146.
Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P., Wasan, P. S., Wang, X. N., Malinarich, F., Malleret, B., Larbi, A., Tan, P., Zhao, H., Poidinger, M., Pagan, S., Cookson, S., Dickinson, R., Dimmick, I., Jarrett, R. F., Renia, L., Tam, J., Song, C., Connolly, J., Chan, J. K., Gehring, A., Bertoletti, A., Collin, M., & Ginhoux, F. (2012). Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity, 37, 60–73.
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., Schreiber, R. D., Murphy, T. L., & Murphy, K. M. (2008). Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science, 322, 1097–1100.
Hochheiser, K., Heuser, C., Krause, T. A., Teteris, S., Ilias, A., Weisheit, C., Hoss, F., Tittel, A. P., Knolle, P. A., Panzer, U., Engel, D. R., Tharaux, P. L., & Kurts, C. (2013). Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. Journal of Clinical Investigation, 123, 4242–4254.
Igyarto, B. Z., Jenison, M. C., Dudda, J. C., Roers, A., Muller, W., Koni, P. A., Campbell, D. J., Shlomchik, M. J., & Kaplan, D. H. (2009). Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. Journal of Immunology, 183, 5085–5093.
Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C. J., Dunbar, P. R., Wadley, R. B., Jeet, V., Vulink, A. J., Hart, D. N., & Radford, K. J. (2010). Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. The Journal of Experimental Medicine, 207, 1247–1260.
Klechevsky, E., & Banchereau, J. (2013). Human dendritic cells subsets as targets and vectors for therapy. Annals of the New York Academy of Sciences, 1284, 24–30.
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., Briere, F., Chaussabel, D., Zurawski, G., Palucka, A. K., Reiter, Y., Banchereau, J., & Ueno, H. (2008). Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity, 29, 497–510.
Klechevsky, E., Liu, M., Morita, R., Banchereau, R., Thompson-Snipes, L., Palucka, A. K., Ueno, H., & Banchereau, J. (2009). Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Human Immunology, 70, 281–288.
Kumamoto, Y., Linehan, M., Weinstein, J. S., Laidlaw, B. J., Craft, J. E., & Iwasaki, A. (2013). CD301b(+) Dermal Dendritic Cells Drive T Helper 2 Cell-Mediated Immunity. Immunity, 39, 733–743.
Langerhans, P. (1868). Uber die nerven der menschlichen haut. Archives of Pathological Anatomy, 44, 325–337.
Lenz, A., Heine, M., Schuler, G., & Romani, N. (1993). Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. Journal of Clinical Investigation, 92, 2587–2596.
Mathers, A. R., Janelsins, B. M., Rubin, J. P., Tkacheva, O. A., Shufesky, W. J., Watkins, S. C., Morelli, A. E., & Larregina, A. T. (2009). Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. Journal of Immunology, 182, 921–933.
Meredith, M. M., Liu, K., Darrasse-Jeze, G., Kamphorst, A. O., Schreiber, H. A., Guermonprez, P., Idoyaga, J., Cheong, C., Yao, K. H., Niec, R. E., & Nussenzweig, M.C. (2012). Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. The Journal of Experimental Medicine, 209, 1153–1165.
Morelli, A. E., Rubin, J. P., Erdos, G., Tkacheva, O. A., Mathers, A. R., Zahorchak, A. F., Thomson, A. W., Falo, L. D. Jr., & Larregina, A. T. (2005). CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. Journal of Immunology, 175, 7905–7915.
Nagao, K., Ginhoux, F., Leitner, W. W., Motegi, S., Bennett, C. L., Clausen, B. E., Merad, M., & Udey, M. C. (2009). Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proceedings of the National Academy of Sciences of the United States of America, 106, 3312–3317.
Nestle, F. O., Zheng, X. G., Thompson, C. B., Turka, L. A., & Nickoloff, B. J. (1993). Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. Journal of Immunology, 151, 6535–6545.
Nestle, F. O., Filgueira, L., Nickoloff, B. J., & Burg, G. (1998). Human dermal dendritic cells process and present soluble protein antigens. The Journal of investigative dermatology, 110, 762–766.
Penel-Sotirakis, K., Simonazzi, E., Peguet-Navarro, J., & Rozieres, A. (2012). Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells. PLos One, 7, e45680.
Poulin, L. F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J. L., Keller, A. M., Joffre, O., Zelenay, S., Nye, E., Le Moine, A., Faure, F., Donckier, V., Sancho, D., Cerundolo, V., Bonnet, D., & Reis e Sousa, C. (2010). Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. The Journal of Experimental Medicine, 207, 1261–1271.
Robbins, S. H., Walzer, T., Dembele, D., Thibault, C., Defays, A., Bessou, G., Xu, H., Vivier, E., Sellars, M., Pierre, P., Sharp, F. R., Chan, S., Kastner, P., & Dalod, M. (2008). Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biology, 9, R17.
Romani, N., Clausen, B. E., & Stoitzner, P. (2010). Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunological Reviews, 234, 120–141.
Satpathy, A. T., Kc, W., Albring, J. C., Edelson, B. T., Kretzer, N. M., Bhattacharya, D., Murphy, T. L., & Murphy, K. M. (2012). Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. The Journal of Experimental Medicine, 209, 1135–1152.
Schmitt, N., Morita, R., Bourdery, L., Bentebibel, S. E., Zurawski, S. M., Banchereau, J., & Ueno, H. (2009). Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity, 31, 158–169.
Schmitt, N., Bustamante, J., Bourdery, L., Bentebibel, S. E., Boisson-Dupuis, S., Hamlin, F., Tran, M. V., Blankenship, D., Pascual, V., Savino, D. A., Banchereau, J., Casanova, J. L., & Ueno, H. (2013). IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans. Blood, 121, 3375–3385.
Schuler, G., & Steinman, R. M. (1985). Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. The Journal of Experimental Medicine, 161, 526–546.
Segura, E., & Villadangos, J. A. (2009). Antigen presentation by dendritic cells in vivo. Current Opinion in Immunology, 21, 105–110.
Sere, K., Baek, J. H., Ober-Blobaum, J., Muller-Newen, G., Tacke, F., Yokota, Y., Zenke, M., & Hieronymus, T. (2012). Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity, 37, 905–916.
Steinman, R. M., & Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. The Journal of Experimental Medicine, 137, 1142–1162.
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012). IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nature Immunology, 13, 753–760.
Zaba, L. C., Fuentes-Duculan, J., Steinman, R. M., Krueger, J. G., & Lowes, M. A. (2007). Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163 + FXIIIA + macrophages. Journal of Clinical Investigation, 117, 2517–2525.
Ziegler, K., & Unanue, E. R. (1981). Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. Journal of Immunology, 127, 1869–1875.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Klechevsky, E. (2015). Functional Diversity of Human Dendritic Cells. In: Schoenberger, S., Katsikis, P., Pulendran, B. (eds) Crossroads Between Innate and Adaptive Immunity V. Advances in Experimental Medicine and Biology, vol 850. Springer, Cham. https://doi.org/10.1007/978-3-319-15774-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-15774-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15773-3
Online ISBN: 978-3-319-15774-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)